Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$2.26M Sell
51,110
-28,653
-36% -$1.19M 3.78% 10
2022
Q1
$3.43M Buy
79,763
+21,096
+36% +$787K 1.83% 14
2021
Q4
$1.92M Buy
+58,667
New +$1.2M 0.75% 66

Other funds holding ASRT

Friess Associates's ASRT Position: Q2 2022 in Review

Friess Associates reduced its Assertio (ASRT) stake by 36% in Q2 2022, selling an estimated $1.19M and leaving 51,110 shares worth $2.26M. The position accounts for 3.78% of the portfolio, ranked #10.

Friess Associates first reported a position in ASRT in Q4 2021 and has held it in 3 quarters since. The position peaked at $3.43M in Q1 2022. 64 funds tracked by Wall St. Rank hold ASRT as of Q2 2022.

  • Friess Associates held 51,110 shares of Assertio worth $2.26M as of Q2 2022.
  • Friess Associates sold 28,653 Assertio shares in Q2 2022, an estimated $1.19M.
  • Assertio made up 3.78% of Friess Associates's portfolio in Q2 2022, its #10 holding.
  • Friess Associates first reported a position in Assertio in Q4 2021 and has held it in 3 quarters since.
  • Friess Associates's Assertio position peaked at $3.43M in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Assertio as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.